Journal article
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
Abstract
Cancer and COVID-19 are both well-established risk factors predisposing to thrombosis. Both disease entities are correlated with increased incidence of venous thrombotic events through multifaceted pathogenic mechanisms involving the interaction of cancer cells or SARS-CoV2 on the one hand and the coagulation system and endothelial cells on the other hand. Thromboprophylaxis is recommended for hospitalized patients with active cancer and …
Authors
DIMAKAKOS E; GOMATOU G; CATALANO M; OLINIC D-M; SPYROPOULOS AC; FALANGA A; MARAVEYAS A; LIEW A; SCHULMAN S; BELCH J
Journal
Anticancer Research, Vol. 42, No. 7, pp. 3261–3274
Publisher
Anticancer Research USA
Publication Date
July 2022
DOI
10.21873/anticanres.15815
ISSN
0250-7005